Ling Dong

Ling Dong is a highly experienced scientific professional with a diverse background in biochemistry and molecular biology. Since September 2019, Ling has served as a Senior Scientist at HiFiBiO Therapeutics after progressing from a Scientist role. Prior to this, from January 2007 to August 2019, Ling held the position of Principal Research Associate at ImmunoGen, Inc., where significant contributions were made in developing antibody-drug conjugates (ADCs) and monoclonal antibodies. Additional experience includes roles at ArQule focusing on cancer drug discovery, and earlier positions at GenWay Biotech, Children’s Hospital/Harvard Medical School, and various academic institutions in Germany, where research involved antibody engineering and neurobiology. Ling holds a Bachelor of Science degree from Zhejiang University.